BRISTOL MYERS SQUIBB CO (BMY)

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Address

ROUTE 206 AND PROVINCE LINE ROAD
PRINCETON, NJ 08543

Founded

1933

Number of Employees

34,100

Website

http://www.bms.com

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s)		 $140,993 $118,300 $342,414 $427,240 $408,842 $419,777 $2,973,864 $6,558,022 $3,236,329 $1,344,303 $140,063 $1,464,559
Average Price $54.09 $63.33 $63.73 $54.86 $60.59 $48.63 $61.06 $61.14 $73.96 $67.37 $53.26 $63.10
# Shares Purchased 2,606,819 1,868,139 5,372,704 7,787,973 6,747,763 8,631,795 48,702,433 107,266,268 43,758,089 19,955,099 2,629,973 23,211,550
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date -9.4% -22.6% -23.1% -10.7% -19.1% 0.8% -19.8% -19.9% -33.7% -27.3% -8.0% -22.3%
S&P 500 Return to Date 181.9% 173.0% 168.6% 129.7% 104.9% 93.1% 74.8% 31.7% 37.3% 31.3% 7.4% 94.0%
Excess Total Return -191.3% -195.6% -191.7% -140.4% -124.0% -92.4% -94.6% -51.5% -71.0% -58.6% -15.4% -116.3%
Quartile Rank
Percentile Rank 27% 25% 23% 32% 27% 35% 19% 31% 19% 14% 27% 27%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed
CORNELIUS JAMES M

BRISTOL MYERS SQUIBB CO
PALMER JAMES B D DR

BRISTOL MYERS SQUIBB CO
GILEAD SCIENCES, INC.

Arcus Biosciences, Inc.
WEST TOGO D JR

FUELCELL ENERGY INC